Paola Di Ciaccio Vanja Nikolac

Size: px
Start display at page:

Download "Paola Di Ciaccio Vanja Nikolac"

Transcription

1 Paola Di Ciaccio Vanja Nikolac

2 ITALYintheHSCfield:HOWISTHISRULED? Directive 2004/23/EC of the European Parliament and of the Council of 31March2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells Directive 2006/17/EC implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells Directive 2006/86/EC of 24 October 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells LAW DECREE November , n.191 Transposition of Directive2004/23/EC on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells LAW DECREE January , n.16 Transposition of Directives 2006/17/EC and 2006/86/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells, as well as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells

3 IDENTIFICATION OF RESPONSIBILITIES STANDARD REQUIREMENTS FOR TISSUE ESTABLISHMENTS (RESPONSIBILITY OF CENTRES) RESPONSIBILITIES OF COMPETENT AUTHORITIES IN SINGLE MEMBER STATES FOR CHECK ON APPLICATION OF TE STANDARDS

4 BLOOD CELLS CompetentAuthoritiesin DONATO Italy: HealthMinisterand RE Regions act through technical bodies, CNT and CNS ORGANS TISSUES

5 ITALIAN NATIONAL TRANSPLANT CENTRE ITALIAN NATIONAL BLOOD CENTRE Law n. 91, Aprile 1, 1999 Art.7 Law n.219. October 21, 2005 They are technical and organizational structures that coordinate the national transplant network (for organs, tissues and cells) and the national blood donation network, respectively They are both located in Rome at the ITALIAN NATIONAL INSTITUTE OF HEALTH A ROLE INBETWEEN HEALTH MINISTRY AND REGIONAL AUTHORITIES

6 DIRECTIVE 23/2004/EC Article 4 implementation of requirements foreseen by Directives Article 6 authorization and accreditation of tissue establishments Article 7 adoption by CAs of adequate control measures and inspection system (every two years) to ensure adherence to Directive requirements Article 8 guarantee traceability Article 9 vigilance on import/export Article 10 data and activity registry and compulsory annual public report Article 11 notification and investigations of serious adverse events and reactions

7 ACTIVITIES IN HSC FIELD Data collectionand processing National coordinatingand supportingbody Training of professionalsand inspectors Issuing of protocols and guidelines Inspections Vigilance and surveillance(saers)

8 HSC Donor identification issues and registries need for high degree of compatibility; about one third of patients requiring HSCT finds a compatible donor within his/her family; patients without a family compatible donor rely then on unrelated donors from international registry. Pat Don

9 International bone marrow registry(i) 23,853,648 (23,246,742 donors and 606,906 CBU's) Bone Marrow Donors Worldwide (BMDW) is the continuing effort to collect the HLA phenotypes and other relevant data of volunteer stem cell donors and cord blood units, and is responsible for the co-ordination of their worldwide distribution. Participants are 73 stem cell donor registries from 52 countries, and 47 cord blood banks from 32 countries. BMDW started as an initiative of the Immunobiology Working Party of the European Group of Blood and Marrow Transplantation (EBMT) in In February 1989 the first edition was distributed, which contained the donor files of eight registries with a total of 155,000 volunteer stem cell donors.

10 International bone marrow registry(ii) Unrelated Cord Blood Units Adults Unrelated Donors - Bone Marrow - Peripheral Blood Stem Cells Cord Blood Banks Registries HLA typing Laboratories (Biological identity profile) Patients Transplant Centre

11 MATCHED UNRELATED DONORS in the world Top five countries in 2012: Germany 6,247 41% USA 3,374 22% Japan 1,332 9% China 639 4% UK-ANT 405 3% Bone marrow Peripheral blood Cord blood

12 WHYTHISISSUEINARTHIQS(I) Increased transplant activity; increase the clinical indications; improvement of supportive care; increasing age of the patients; increasing age of donors.

13 WHYTHISISSUEINARTHIQS(II) Risks related to HSC donation are generally considered as non-existent. However, over the years various reports from individual transplantation centers and donor registries have shown that the collection procedure can be related to the onset of a number of symptoms, with changes in vital signs and/or examinations, in the majority of cases of moderate and transient entity. Some serious adverse events/reactions (including death) have been reported. HSC donor follow-up is widely recognized to be insufficient, especially regarding related donors.

14 HOWWEAREGOINGTOTACKLETHIS Revision of existing standards and their harmonization with EU directives, in close collaboration with international registry and professionals scientific societies; Definition of European guidelines to assure high leveldonorssafetyinallms.

15 CROATIA- Competent Authority Population 2011 census 4,284,889 Area 56,594 km2 Capital Zagreb Competent Authority Ministry of Health

16 Croatian Ministry of Health- organisational chart

17 Croatian Ministry of Health Competent authority for blood tissues and cells organs assisted reproductive technologies Institute for transplantation and biomedicine Data collection Authorisation Regulatory issues Organisational and financial issues Service for Inspection of Blood, Tissues and Cells Inspection Supervision of the implementation of acts and other regulations Vigilance (adverse reaction and event reporting system)

18 CROATIAN LEGISLATION IN THE FIELD OF HSC 2nd, improved set of legislation transposing EUTCDs Directive 2004/23/EC of the European Parliament and of the Council of 31March2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells ACTON THE APPLICATION OF HUMAN TISSUES AND CELLS December

19 CROATIAN LEGISLATION IN THE FIELD OF HSC Directive 2006/17/EC implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells Directive 2006/86/EC of 24 October 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells Commission Decision 2010/453/EU of 3 August 2010establishing guidelines concerning the conditions of inspections and control measures, and on the training and qualification of officials, in the field of human tissues and cells provided for in Directive 2004/23/EC of the European Parliament and of the Council Ordinance On the conditions in terms of premises, personnel, medical and technical equipment and quality system for the performance of the activities of collection, procurement, testing, processing, preservation, storage and distribution of human tissues and cells June Ordinance On the method of monitoring serious adverse events and serious adverse reactions in the field of application of human tissues and cells, the method of keeping records, the notification time limits and the content and format of the annual report April Ordinance On the requirements concerning professional qualifications and professional training and on the method of conducting supervision in the field of application of human tissues and cells April

20 CBB: deserves special attention Umbilical Cord Blood First transplantation in 1988., in Paris, in a patient with Fanconi anemia First unrelated cord blood transplant in adult in In1997. International NetCordFoundation,a non-profit association of umbilical cord blood banks was established- today aprox. 35 banks and registries are members Intheglobal network of CBB thereare aprox UCB units (ElianeGluckman, AnnalisaRuggeri, FernandaVolt, Renato Cunha, KarimBoudjedirandVandersonRocha: Milestones in umbilical cord blood transplantation, 2011 Blackwell Publishing Ltd, British Journal of Haematology, 154, ) More than units have been distributed (Ibid.)

21 CBB deserves special attention Umbilical Cord Blood mobility source

22 CBB deserves special attention Umbilical Cord Blood Long term leukaemia-free survival in children (Wagner et al, 1996; Locatelli et al, 1999) and adults (Cairo& Wagner, 1997; Rubinstein et al, 1998; Laughlin et al, 2001; Sanz et al, 2001) is similar for cord blood transplant recipients and matched unrelated bone marrow transplant recipients Improvedresults, mostly in adults, with the use of double cord blood transplants (Barker et al, 2005; Brunstein et al, 2007; Rocha et al, 2010) Notch-mediated expansionresultingin rapidengraftment (ColleenDelaney, ShellyHeimfeld, Carolyn Brashem-Stein, Howard Voorhies, Ronald L. Manger, and Irwin D. Bernstein1; Notch-mediated expansion of Human Cord Blood Progenitor Cells Capable of Rapid Myeloid Reconstitution, Nat Med February; 16(2): 232. doi: /nm.2080) Shows that storing of high quality units is not only worth but essential

23 CBB deserves special attention Umbilical Cord Blood- advantages Simple collection procedure Has to berisk for donor-a mother or a newborn No donor attrition Low risk of viral transmitting Immediate availability in emergency Easy delivery Grater proportion of rare haplotypes present in UCB banks then in BMT registries (Anfisa Stanevsky a, Gal Goldstein b, Arnon Nagler: Umbilical cord blood transplantation: Pros, cons and beyond)

24 Targets Developing guidelines for CB banking establishing common goodpracticeforthefieldinms Setting guide for CBB inspection leading to harmonisation in inspection practice (including inspectors education and skills, inspection documentation, performance) and mutual recognition of EU inspection bodies

25

REPUBLIC OF LITHUANIA LAW ON DONATION AND TRANSPLANTATION OF HUMAN TISSUES, CELLS AND ORGANS. 19 November 1996 No I-1626 Vilnius

REPUBLIC OF LITHUANIA LAW ON DONATION AND TRANSPLANTATION OF HUMAN TISSUES, CELLS AND ORGANS. 19 November 1996 No I-1626 Vilnius REPUBLIC OF LITHUANIA LAW ON DONATION AND TRANSPLANTATION OF HUMAN TISSUES, CELLS AND ORGANS 19 November 1996 No I-1626 Vilnius (As last amended on 12 May 2016 No XII-2344) CHAPTER I GENERAL PROVISIONS

More information

LEGISLATIVE FRAMEWORKS AND ETHICS OF DONATION. Jeff Szer, Royal Melbourne Hospital, Australia

LEGISLATIVE FRAMEWORKS AND ETHICS OF DONATION. Jeff Szer, Royal Melbourne Hospital, Australia LEGISLATIVE FRAMEWORKS AND ETHICS OF DONATION Jeff Szer, Royal Melbourne Hospital, Australia Donation of HPC Autologous HPC-A HPC-M Allogeneic Family member Volunteer Unrelated HPC-A HPC-M HPC-C Ethical

More information

Transparency, Equity, Ethics: access to care. quality of life. Improving. and patients. An Agency of the French Ministry of Health

Transparency, Equity, Ethics: access to care. quality of life. Improving. and patients. An Agency of the French Ministry of Health An Agency of the French Ministry of Health Transparency, Equity, Ethics: Improving access to care and patients quality of life AgenceBiomedecine_Plaquette_GB.indd 1 25/08/14 12:15 Contents P.1 Agence de

More information

European actions in the field of transplantation & blood transfusion

European actions in the field of transplantation & blood transfusion European actions in the field of transplantation & blood transfusion Andrzej Rys Director Directorate Health Systems and Products Madrid, 27 June 2013 1 Blood Tissues and cells Organs 2 Blood transfusion

More information

Introduction to EU 'SoHO' Sector Screening Meeting with the Republic of Serbia December 5, 2014 Directorate General for Health and Consumers Unit D4

Introduction to EU 'SoHO' Sector Screening Meeting with the Republic of Serbia December 5, 2014 Directorate General for Health and Consumers Unit D4 Introduction to EU 'SoHO' Sector Screening Meeting with the Republic of Serbia December 5, 2014 Directorate General for Unit D4 1. Introduction: SoHO & the Legal Basis 2. The Legislative Framework 3. Blood

More information

Guidance for establishing a hematopoietic progenitor cells donor follow-up registry

Guidance for establishing a hematopoietic progenitor cells donor follow-up registry Guidance for establishing a hematopoietic progenitor cells donor follow-up registry ARTHIQS Deliverable 8 Work Package 5 ARTHIQS (Grant agreement n. 20132101) has received funding from the European Commission

More information

4nd Patient and Family Day

4nd Patient and Family Day 4nd Patient and Family Day EBMT Slide template Barcelona 7 February 2008 EBMT 2010 Vienna, Austria ; www.ebmt.org History of Stem Cell Transplantation Appelbaum et al, NEJM 2006 What is EBMT? Scientific,

More information

HUNGARIAN NATIONAL BLOOD TRANSFUSION SERVICE. Dr. Klara Baroti-Tóth, PhD IPFA/PEI 19 th International Workshop Budapest, May, 2012.

HUNGARIAN NATIONAL BLOOD TRANSFUSION SERVICE. Dr. Klara Baroti-Tóth, PhD IPFA/PEI 19 th International Workshop Budapest, May, 2012. HUNGARIAN NATIONAL BLOOD TRANSFUSION SERVICE Dr. Klara Baroti-Tóth, PhD IPFA/PEI 19 th International Workshop Budapest, 23-24 May, 212. BLOOD DONATION G I V I N G I S G O O D ORGAN COORDINATION OFFICE

More information

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the

More information

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the

More information

Accreditation of BMT units & EU Regulations

Accreditation of BMT units & EU Regulations Accreditation of BMT units & EU Regulations April 1, 2008 EBMT Annual Meeting Workshop: EU regulation/standardisation of cellular therapy Presentation: JACIE: aims and current activities EU regulation

More information

Title: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION

Title: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION Title: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION Authorised by: Executive Officer Contributing Authors: ABMDR Scientific Expert Advisory Committee Sally Gordon Dr Hilary Blacklock Raewyn

More information

Cord Blood Transplant. E. Gluckman Eurocord ESH-EBMT training course Vienna 2014

Cord Blood Transplant. E. Gluckman Eurocord ESH-EBMT training course Vienna 2014 Cord Blood Transplant E. Gluckman Eurocord ESH-EBMT training course Vienna 2014 Background Since 1988, umbilical cord blood (CB) has been successfully used to treat children and adults needing stem cell

More information

EBMT Society EBMT. History Organisation Studies Activity Philosophy. EBMT Website. European Group for Blood and Marrow Transplantation

EBMT Society EBMT. History Organisation Studies Activity Philosophy. EBMT Website. European Group for Blood and Marrow Transplantation EBMT EBMT Organisation and Activities J Apperley 13th. ESH-EBMT Training Course Targu Mures May 24 26, 2010 History Organisation Studies Activity Philosophy EBMT Website www.ebmt.org EBMT Society European

More information

Haplo vs Cord vs URD Debate

Haplo vs Cord vs URD Debate 3rd Annual ASBMT Regional Conference for NPs, PAs and Fellows Haplo vs Cord vs URD Debate Claudio G. Brunstein Associate Professor University of Minnesota Medical School Take home message Finding a donor

More information

EU BLOOD AND TISSUES DIRECTIVES

EU BLOOD AND TISSUES DIRECTIVES 10th European Haemovigilance Seminar (EHS) February 28 Frankfurt/Main, Germany EU BLOOD AND TISSUES DIRECTIVES European Commission Health and Consumer Protection Directorate General Public Health and Risk

More information

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 8.12.2008 COM(2008) 818 final 2008/0238 (COD) Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on standards of quality and safety

More information

Integrating and strengthening the European research area *

Integrating and strengthening the European research area * P5_TA(2003)0506 Integrating and strengthening the European research area * European Parliament legislative resolution on the proposal for a Council decision amending Decision 2002/834/EC on the specific

More information

Study for the improvement of umbilical cord blood sampling using a new trial apparatus

Study for the improvement of umbilical cord blood sampling using a new trial apparatus bs_bs_banner doi:10.1111/jog.12179 J. Obstet. Gynaecol. Res. Vol. 40, No. 2: 405 409, February 2014 Study for the improvement of umbilical cord blood sampling using a new trial apparatus Naoki Masaoka

More information

The National Marrow Donor Program. Graft Sources for Hematopoietic Cell Transplantation. Simon Bostic, URD Transplant Recipient

The National Marrow Donor Program. Graft Sources for Hematopoietic Cell Transplantation. Simon Bostic, URD Transplant Recipient 1988 199 1992 1994 1996 1998 2 22 24 26 28 21 212 214 216 218 Adult Donors Cord Blood Units The National Donor Program Graft Sources for Hematopoietic Cell Transplantation Dennis L. Confer, MD Chief Medical

More information

European activities in the field of Human Substances - Organ Donation and Transplantation

European activities in the field of Human Substances - Organ Donation and Transplantation European activities in the field of Human Substances - Organ Donation and Transplantation Journalist Workshop 9 October 2012 Hélène Le Borgne, Policy Officer for Organ donation & transplantation, Team

More information

EUROPEAN UNION. Brussels, 29 June 2010 (OR. en) 2008/0238 (COD) PE-CONS 19/1/10 REV 1 SAN 114 CODEC 431

EUROPEAN UNION. Brussels, 29 June 2010 (OR. en) 2008/0238 (COD) PE-CONS 19/1/10 REV 1 SAN 114 CODEC 431 EUROPEAN UNION THE EUROPEAN PARLIAMT THE COUNCIL Brussels, 29 June 2010 (OR. en) 2008/0238 (COD) PE-CONS 19/1/10 REV 1 SAN 114 CODEC 431 LEGISLATIVE ACTS AND OTHER INSTRUMTS Subject: DIRECTIVE OF THE EUROPEAN

More information

L 256/32 Official Journal of the European Union

L 256/32 Official Journal of the European Union L 256/32 Official Journal of the European Union 1.10.2005 COMMISSION DIRECTIVE 2005/61/EC of 30 September 2005 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards

More information

Haematopoietic stem cell transplantation (SCT)

Haematopoietic stem cell transplantation (SCT) HAEMATOPOIETIC TEM CELL TRANPLANTATION FOR CHILREN IN BELGIUM Marie-Françoise resse 1 & Yves Beguin 2 1 epartment of Paediatrics, ivision of Hemato-Oncology, UHOPL, University of Liege, Liège, Belgium;

More information

Quality and Safety of HSCT in Autoimmune Diseases

Quality and Safety of HSCT in Autoimmune Diseases Quality and Safety of HSCT in Autoimmune Diseases Dr John Snowden Stem Cell Transplant Programme Director Sheffield Teaching Hospitals and University of Sheffield & JACIE Medical Director 1 HSCT is GROWING

More information

Bone marrow transplantation for PID

Bone marrow transplantation for PID BMT Bone marrow transplantation for PID hello@piduk.org 0800 987 898 www.piduk.org About this leaflet Bone marrow transplant (BMT; also known as haematopoietic stem cell transplant or HSCT) is increasingly

More information

15. Procuring, processing and transporting gametes and

15. Procuring, processing and transporting gametes and 15. Procuring, processing and transporting gametes and embryos Version 6.0 On this page: : Extracts from the HFE Act Directions HFEA guidance: Documented procedures: general Patient selection and procurement

More information

Documentation of Changes to EFI Standards: v 5.6.1

Documentation of Changes to EFI Standards: v 5.6.1 Modified Standard B - PERSONNEL QUALIFICATIONS B1.000 The laboratory must employ one or more individuals who meet the qualifications and fulfil the responsibilities of the Director/Co-Director, Technical

More information

RESOLUTION CFM No /2013

RESOLUTION CFM No /2013 RESOLUTION CFM No. 2.013/2013 (Published in Federal Official Gazette (D.O.U.) dated May 9 th, 2013, Section I, page 119) Adopts the ethical standards for use of assisted reproduction techniques, annexed

More information

DIRECTIVES. (Text with EEA relevance)

DIRECTIVES. (Text with EEA relevance) L 238/44 DIRECTIVES COMMISSION DIRECTIVE (EU) 2017/1572 of 15 September 2017 supplementing Directive 2001/83/EC of the European Parliament and of the Council as regards the principles and guidelines of

More information

NATIONAL BLOOD TRANSFUSION SERVICES STRATEGY

NATIONAL BLOOD TRANSFUSION SERVICES STRATEGY FEDERAL DEMOCRATIC REPUBLIC OF ETHIOPIA MINISTRY OF HEALTH NATIONAL BLOOD TRANSFUSION SERVICES STRATEGY February 2005 Addis Ababa Ethiopia Acknowledgement The Ministry of Health of the Federal Democratic

More information

GLP in the European Union Ecolabel detergents, GLP and accreditation

GLP in the European Union Ecolabel detergents, GLP and accreditation GLP in the European Union Ecolabel detergents, GLP and accreditation Maik Schmahl Brussels, 25/03/2010 Chemicals Unit Outline What is GLP? How has it developed? The role of the Member States, the European

More information

Human tissues and cells annual report 2011

Human tissues and cells annual report 2011 Human tissues and cells annual report 2011 2012 Human tissues and cells Annual report Danish Health and Medicines Authority, 2012. This publication can be freely cited with a clear indication of source.

More information

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS EUROPEAN COMMISSION Brussels, 17.6.011 COM(011) 35 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

More information

Legislation concerning food donations in EU Member States and Croatia. Jasenka Begić, mag. ling., mag. litt. comp.

Legislation concerning food donations in EU Member States and Croatia. Jasenka Begić, mag. ling., mag. litt. comp. Legislation concerning food donations in EU Member States and Croatia Jasenka Begić, mag. ling., mag. litt. comp. Content 1. The scope of the problem 2. Overview of the current legislation and practices

More information

Single European Code for Tissues and Cells

Single European Code for Tissues and Cells Single European Code for Tissues and Cells Mr Richard Forde, Blood Tissues and Organs Inspector Health Products Regulatory Authority 19 th Overview: The Single European Code (SEC): Legislative Basis; Eurocet

More information

Implementation of the Stem Cell Therapeutic and Research Act of 2005

Implementation of the Stem Cell Therapeutic and Research Act of 2005 Implementation of the Stem Cell Therapeutic and Research Act of 2005 The 6 th Annual Somatic Cell Therapy Symposium Bethesda, MD September 26, 2006 James F. Burdick, M.D. U.S. Department of Health and

More information

Comparability and quality of experimental data under different quality systems. S. Caroli Istituto Superiore di Sanità Rome

Comparability and quality of experimental data under different quality systems. S. Caroli Istituto Superiore di Sanità Rome Comparability and quality of experimental data under different quality systems S. Caroli Istituto Superiore di Sanità Rome Programme of this presentation Part I. Background information Part II. Key aspects

More information

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014 Good Laboratory Practice EU-Serbia screening meeting Brussels, 19 June 2014 Table of contents 1. Background information on the principles of GLP 2. EU legal basis for GLP 3. Role of Member States 4. Role

More information

Safety of cornea for transplantation, the role of the Eye-Bank. M. Corneli

Safety of cornea for transplantation, the role of the Eye-Bank. M. Corneli Safety of cornea for transplantation, the role of the Eye-Bank M. Corneli Florence, 22th February 2018 Let s think If I needed a cornea transplant would I be comfortable accepting a cornea distributed

More information

Fondazione Banco Alimentare Onlus Via Legnone 4 _ Milano _ T _ F _ E _ CF

Fondazione Banco Alimentare Onlus Via Legnone 4 _ Milano _ T _ F _ E _ CF June 2014 Position statement of the Fondazione Banco Alimentare Onlus The Fondazione Banco Alimentare Onlus (hereinafter, FBAO ), through its network of 21 Food Banks in Italy, is committed to fight against

More information

EUROPEAN UNION. Brussels, 15 October 2007 (OR. en) 2005/0227 (COD) PE-CONS 3627/07 MI 149 ECO 83 SAN 123 CODEC 621

EUROPEAN UNION. Brussels, 15 October 2007 (OR. en) 2005/0227 (COD) PE-CONS 3627/07 MI 149 ECO 83 SAN 123 CODEC 621 EUROPEAN UNION THE EUROPEAN PARLIAMT Brussels, 15 October 2007 (OR. en) THE COUNCIL 2005/0227 (COD) PE-CONS 3627/07 MI 149 ECO 83 SAN 123 CODEC 621 LEGISLATIVE ACTS AND OTHER INSTRUMTS Subject: Regulation

More information

Consultation document on Organ Donation and Transplantation Response Form

Consultation document on Organ Donation and Transplantation Response Form Consultation document on Organ Donation and Transplantation Response Form Contact details of person and/or institution submitting comments Name of person Address e-mail address Knud Erben erben@ceapir.org

More information

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents 2007R1394 EN 02.07.2012 001.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B REGULATION (EC) No 1394/2007 OF THE EUROPEAN

More information

ART Issues and Regulation: a global perspective. Lori P. Knowles BA LLB BCL MA LLM

ART Issues and Regulation: a global perspective. Lori P. Knowles BA LLB BCL MA LLM ART Issues and Regulation: a global perspective Lori P. Knowles BA LLB BCL MA LLM International Issues Expanded parenthood Consent issues Embryo transfer Commercialization Safety Traceability Governance

More information

Factors Influencing Haematopoietic Progenitor cell transplant outcome Optimising donor selection

Factors Influencing Haematopoietic Progenitor cell transplant outcome Optimising donor selection Factors Influencing Haematopoietic Progenitor cell transplant outcome Optimising donor selection Alison Logan Transplantation Laboratory Manchester Royal Infirmary Haematopoietic progenitor cell transplants

More information

Il ruolo delle VEQ per la sicurezza trasfusionale

Il ruolo delle VEQ per la sicurezza trasfusionale Il ruolo delle VEQ per la sicurezza trasfusionale The role of EQA for transfusion safety Giulio Pisani CNCF Ist. Sup. Sanità Global Blood Product Safety, Roma 10 aprile 2019 Blood transfusion is an essential

More information

HAEMATOPOIETIC STEM CELL TRANSPLANTATION

HAEMATOPOIETIC STEM CELL TRANSPLANTATION PRIMARY IMMUNODEFICIENCIES HAEMATOPOIETIC STEM CELL TRANSPLANTATION HAEMATOPOIETIC STEM CELL TRANSPLANTATION 1 PRIMARY IMMUNODEFICIENCIES KEY ABBREVIATIONS CID GvHD HSCT IPOPI PID SCID BMT HSC Combined

More information

Correlation of umbilical cord blood volume with CD34+ cells concentration

Correlation of umbilical cord blood volume with CD34+ cells concentration IJBTI 2011 ;1 :1 2-1 6. Chandra et al. 1 2 ORIGINAL ARTICLE OPEN ACCESS Correlation of umbilical cord blood volume with CD34+ cells concentration Tulika Chandra, Sheeba Afreen, Ashutosh Kumar, Uma Singh

More information

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 09 JUNE 2015

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 09 JUNE 2015 EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL sante.ddg2.g.dir(2015)2952292 SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 09 JUNE 2015

More information

(Adopted by the Committee of Ministers on 19 January 2011 at the 1103rd meeting of the Ministers Deputies)

(Adopted by the Committee of Ministers on 19 January 2011 at the 1103rd meeting of the Ministers Deputies) Resolution CM/ResAP(2011)1 on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients (Adopted by the Committee of Ministers on 19 January

More information

FoodDrinkEurope Position on GLP studies

FoodDrinkEurope Position on GLP studies FoodDrinkEurope Position on GLP studies Content of the presentation Introduction to GLP Importance of GLP for the food industry Use of GLP based on the example of novel foods Conclusions GLP what is it?

More information

ECHA Committee for Risk Assessment: Evaluation of the Classification and Labelling of Glyphosate

ECHA Committee for Risk Assessment: Evaluation of the Classification and Labelling of Glyphosate ECHA Committee for Risk Assessment: Evaluation of the Classification and Labelling of Glyphosate Tim Bowmer, Committee Chairman Ari Karjalainen, Dossier Manager for Glyphosate 10 May 2017 1 Established

More information

Placental and Umbilical Cord Blood as a Source of Stem Cells

Placental and Umbilical Cord Blood as a Source of Stem Cells Placental and Umbilical Cord Blood as a Source of Stem Cells Policy Number: 7.01.50 Last Review: 12/2018 Origination: 12/2001 Next Review: 12/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue

More information

Transplantation - Challenges for the future. Dr Gordon Cook S t James s Institute of Oncology, Leeds Teaching Hospitals Trust

Transplantation - Challenges for the future. Dr Gordon Cook S t James s Institute of Oncology, Leeds Teaching Hospitals Trust Transplantation - Challenges for the future Dr Gordon Cook S t James s Institute of Oncology, Leeds Teaching Hospitals Trust Bone Marrow Transplantation Timeline, 1957-2006 Appelbaum F. N Engl J Med 2007;357:1472-1475

More information

WHAT DO MANUFACTURERS AND IMPORTERS HAVE TO DO TO PREPARE FOR EU MEMBERSHIP?

WHAT DO MANUFACTURERS AND IMPORTERS HAVE TO DO TO PREPARE FOR EU MEMBERSHIP? WHAT DO MANUFACTURERS AND IMPORTERS HAVE TO DO TO PREPARE FOR EU MEMBERSHIP? pharmaceutical regulatory affairs consulting and education www.rapharm.eu Vesna Koblar, MD. PhD. EU28: Science, Medicines, Health

More information

Cord Blood Stem Cell Banking and Transplantation

Cord Blood Stem Cell Banking and Transplantation Cord Blood Stem Cell Banking and Transplantation JOHN W. ADAMSON New York Blood Center, New York, New York, USA Key Words. Cord blood Stem cells Cord blood banking Cord blood transplantation. Cord blood.stern

More information

(Legislative acts) REGULATIONS

(Legislative acts) REGULATIONS 31.12.2010 Official Journal of the European Union L 348/1 I (Legislative acts) REGULATIONS REGULATION (EU) No 1235/2010 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 15 December 2010 amending, as regards

More information

Rob Wynn RMCH & University of Manchester, UK. HCT in Children

Rob Wynn RMCH & University of Manchester, UK. HCT in Children Rob Wynn RMCH & University of Manchester, UK HCT in Children Summary Indications for HCT in children Donor selection for Paediatric HCT Using cords Achieving engraftment in HCT Conditioning Immune action

More information

Overview of Blood Transfusion System of Iran:

Overview of Blood Transfusion System of Iran: Report Article Overview of Blood Transfusion System of Iran: 2002-2011 AM Cheraghali High Institute for Research and Education on Transfusion Medicine, Iran Blood Transfusion Organization and University

More information

Hematopoietic Stem Cell Transplantation for Fanconi Anemia

Hematopoietic Stem Cell Transplantation for Fanconi Anemia Hematopoietic Stem Cell Transplantation for Fanconi Anemia John E. Wagner, M.D. Blood and Marrow Transplant Program University of Minnesota Cell Therapy for Pediatric Diseases NHLBI PACT Workshop 14 15

More information

Quality Assurance Policy. for the. Procurement of HIV Point-of-Care Technology. under the UNITAID Grant

Quality Assurance Policy. for the. Procurement of HIV Point-of-Care Technology. under the UNITAID Grant Quality Assurance Policy for the Procurement of HIV Point-of-Care Technology under the UNITAID Grant UNICEF Supply Division Quality Assurance Centre and Health Technology Centre Revisions Version Date

More information

Update from FDA Office of Regulatory Affairs

Update from FDA Office of Regulatory Affairs Update from FDA Office of Regulatory Affairs Ellen F. Morrison Assistant Commissioner for Medical Products and Tobacco Operations Office of Regulatory Affairs U.S. Food and Drug Administration 1 The Impact

More information

EUROPEAN COMMISSION. Modus Operandi for the management of new food safety incidents with a potential for extension involving a chemical substance

EUROPEAN COMMISSION. Modus Operandi for the management of new food safety incidents with a potential for extension involving a chemical substance EUROPEAN COMMISSION Modus Operandi for the management of new food safety incidents with a potential for extension involving a chemical substance The Health and Consumer Protection Directorate-General of

More information

BMTCN REVIEW COURSE PRE-TRANSPLANT CARE

BMTCN REVIEW COURSE PRE-TRANSPLANT CARE BMTCN REVIEW COURSE PRE-TRANSPLANT CARE Jennifer Shamai MS, RN, AOCNS, BMTCN Professional Practice Leader Department of Clinical Practice And Professional Education Click How to edit the Master Experts

More information

What are stem cells? A stem cell can differentiate into any one of 220 different specialised cells in the body STEM CELLS

What are stem cells? A stem cell can differentiate into any one of 220 different specialised cells in the body STEM CELLS What are stem cells? Stem cells are often called MASTER CELLS, and form the foundation for your entire body as building blocks for the blood, immune system, tissue and organs. They can REPLICATE or REGENERATE

More information

Applicant (Invented) Name Strength Pharmaceutical Form. UMAN BIG 180 I.E./ml Injektionslösung. UMAN BIG 180 IU/ml Solution for injection

Applicant (Invented) Name Strength Pharmaceutical Form. UMAN BIG 180 I.E./ml Injektionslösung. UMAN BIG 180 IU/ml Solution for injection ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANTS AND MARKETING AUTHORISATION HOLDER IN THE MEMBER STATE 1 Member State EU/EEA Marketing

More information

Industry and globalisation of herbal medicines

Industry and globalisation of herbal medicines TradReg 2017 Bonn 14 September 2017 Industry and globalisation of herbal medicines Dr Hubertus Cranz Director General Association of the European Self-Medication Industry (AESGP) 7 Avenue de Tervuren,

More information

Medical Policy. MP Placental and Umbilical Cord Blood as a Source of Stem Cells

Medical Policy. MP Placental and Umbilical Cord Blood as a Source of Stem Cells Medical Policy MP 7.01.50 BCBSA Ref. Policy: 7.01.50 Last Review: 01/30/2018 Effective Date: 01/30/2018 Section: Surgery Related Policies 8.01.20 Hematopoietic Cell Transplantation for Non- Hodgkin Lymphomas

More information

FINLAND ON A ROAD TOWARDS A MODERN LEGAL BIOBANKING INFRASTRUCTURE

FINLAND ON A ROAD TOWARDS A MODERN LEGAL BIOBANKING INFRASTRUCTURE Postrefereed, preprint version of the text published at European Journal of Health Law 2013(3)28994. Link to the publisher s website: http://www.brill.com/europeanjournalhealthlaw Sirpa Soini FINLAND ON

More information

Wyss Zürich Regulatory Affairs Seminar

Wyss Zürich Regulatory Affairs Seminar Wyss Zürich Regulatory Affairs Seminar Hospital Exemption & Compassionate Use EU Framework Catherine Longeval Koen T Syen Zürich, 5 July 2017 1 Table of contents Introduction Hospital Exemption Implementation

More information

Placing Donation within End-of-Life Care in Intensive Care in Europe

Placing Donation within End-of-Life Care in Intensive Care in Europe Placing Donation within End-of-Life Care in Intensive Care in Europe Prof Chris Rudge CBE FRCS Madrid June 28 th 2013 Agenda 1. Introduction 1. The wide variation in Organ Donation across Europe 2. What

More information

FROM STRENGTH TO STRENGTH

FROM STRENGTH TO STRENGTH The Anthony Nolan and NHS Stem Cell Registry Annual Review of 2016 FROM STRENGTH TO STRENGTH Anthony Nolan DKMS UK NHS Blood and Transplant Welsh Blood Service 2 Heathgate Place 75-87 Agincourt Road London

More information

Workshop on Contingency planning and practical activities in surveillance on Bluetongue and FMD

Workshop on Contingency planning and practical activities in surveillance on Bluetongue and FMD Workshop on Contingency planning and practical activities in surveillance on Bluetongue and FMD AGR 51515 Organised in co-operation with Ministry of Agriculture, Forestry and Water Management, Veterinary

More information

OPERATIONS AND PATIENT SERVICES USER GUIDE. Procedures for transplant centres and international establishments

OPERATIONS AND PATIENT SERVICES USER GUIDE. Procedures for transplant centres and international establishments OPERATIONS AND PATIENT SERVICES USER GUIDE Procedures for transplant centres and international establishments 1. INTRODUCTION 9 1.1. Introduction 9 1.2. User Guide 9 1.3. Services Provided by Anthony Nolan

More information

Clinical Trials in Third Countries

Clinical Trials in Third Countries Clinical Trials in Third Countries meeting, 29 January 2015 Presented by Fergus Sweeney European Medicines Agency An agency of the European Union Overview Distribution of clinical trials submitted in support

More information

Botanicals and botanical preparations in the EU: evolution through time towards full harmonisation. Opportunities and challenges.

Botanicals and botanical preparations in the EU: evolution through time towards full harmonisation. Opportunities and challenges. Botanicals and botanical preparations in the EU: evolution through time towards full harmonisation. Opportunities and challenges.part III- Marketing botanical food supplements in Italy Vittorio Silano

More information

MOTION FOR A RESOLUTION

MOTION FOR A RESOLUTION EUROPEAN PARLIAMT 2009-2014 Plenary sitting 07.3.2012 B7-0000/2012 MOTION FOR A RESOLUTION further to Question for Oral Answer B7-0000/2012 pursuant to Rule 115(5) of the Rules of Procedure on Defective

More information

Bone Marrow Transplantation and the Potential Role of Iomab-B

Bone Marrow Transplantation and the Potential Role of Iomab-B Bone Marrow Transplantation and the Potential Role of Iomab-B Hillard M. Lazarus, MD, FACP Professor of Medicine, Director of Novel Cell Therapy Case Western Reserve University 1 Hematopoietic Cell Transplantation

More information

SUMMARY COMPARISON OF NATIONAL PLANS AND PRACTICES. Domenica Taruscio

SUMMARY COMPARISON OF NATIONAL PLANS AND PRACTICES. Domenica Taruscio Presentation to the European Conference Rare Diseases Luxembourg, 21-22 June, 2005 SUMMARY COMPARISON OF NATIONAL PLANS AND PRACTICES Domenica Taruscio taruscio@iss.it http://www.cnmr.iss.it Co-ordinator

More information

Blood Drive Coordinator Handbook.

Blood Drive Coordinator Handbook. Blood Drive Coordinator Handbook www.communitybloodservices.org How Blood Donations Help Save Lives... Eleanor Hahn Eleanor Hahn was just 15 when she and her family received startling news: Eleanor had

More information

Stem Cell Transplantation for Severe Aplastic Anemia

Stem Cell Transplantation for Severe Aplastic Anemia Number of Transplants 10/24/2011 Stem Cell Transplantation for Severe Aplastic Anemia Claudio Anasetti, MD Professor of Oncology and Medicine Chair, Blood and Marrow Transplant Dpt Moffitt Cancer Center

More information

Sickle Cell Diseasechronic. curable disease? Objectives. Why would a family ask about cure for SCD?

Sickle Cell Diseasechronic. curable disease? Objectives. Why would a family ask about cure for SCD? Sickle Cell Diseasechronic illness or curable disease? Gregory M.T. Guilcher MD, FRCPC, FAAP Objectives To review the general principles of hematopoietic stem cell transplantation (HSCT), including risks

More information

BMA response to the European Commission Green Paper on the European Workforce for Health

BMA response to the European Commission Green Paper on the European Workforce for Health BMA response to the European Commission Green Paper on the European Workforce for Health The British Medical Association (BMA) is the UK s leading voluntary professional association and trade union for

More information

Cooperation between HALMED and GMP Inspectorate in supervision of manufacturers: Croatia s experience so far

Cooperation between HALMED and GMP Inspectorate in supervision of manufacturers: Croatia s experience so far Cooperation between HALMED and GMP Inspectorate in supervision of manufacturers: Croatia s experience so far Ana Boban, MPharm. Agency for Medicinal Product and Medical Devices of Croatia Dubrovnik, 06.05.2013.

More information

Presentation of Istituto Superiore di Sanità, Rome, Italy

Presentation of Istituto Superiore di Sanità, Rome, Italy Presentation of Istituto Superiore di Sanità, Rome, Italy Health Literacy and Health Education Graz, November 24, 2011 Maurella Della Seta, Documentation Service, ISS maurella.dellaseta@iss.it Istituto

More information

GMP IN BLOOD ESTABLISHMENTS: A BASIC ELEMENT FOR PLASMA QUALITY

GMP IN BLOOD ESTABLISHMENTS: A BASIC ELEMENT FOR PLASMA QUALITY GMP IN BLOOD ESTABLISHMENTS: A BASIC ELEMENT FOR PLASMA QUALITY Dr. Christian Schärer Swissmedic, Swiss Agency for Therapeutic Products Inspectorates, Hallerstrasse 7 CH-3000 Bern 9 christian.schaerer@swissmedic.ch

More information

EBMT Complications and Quality of Life Working Party Educational Course

EBMT Complications and Quality of Life Working Party Educational Course EBMT Complications and Quality of Life Working Party Educational Course Organisers: R. Duarte, G. Basak 23-24 October 2014, Warsaw, Poland #EBMT2014 www.ebmt.org EBMT Complications and Quality of Life

More information

Protocol Number: 10-CBA National Clinical Trial (NCT) Identified Number: NCT

Protocol Number: 10-CBA National Clinical Trial (NCT) Identified Number: NCT A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications

More information

MEDICALLY ASSISTED PROCREATION: THE PORTUGUESE PROJECTS

MEDICALLY ASSISTED PROCREATION: THE PORTUGUESE PROJECTS MEDICALLY ASSISTED PROCREATION: THE PORTUGUESE PROJECTS M.J. Carneiro de Sousa; Alice Gouveia; J. Pinto da Costa Biomedical Sciences Institute; Oporto University Portugal INTRODUCTION Rapid evolution in

More information

21/05/2018. Continuing Education. Presentation Recording. learn.immucor.com

21/05/2018. Continuing Education. Presentation Recording. learn.immucor.com Transplant Webinar Series: Ep. 6 Donor Selection for Haematopoietic Stem Cell Transplantation Future Webinars The Role of NGS in the Transplant Setting Featuring Dr Sujatha Krishnakumar Sirona Genomics,

More information

The TTSN - A Collaborative Biovigilance System

The TTSN - A Collaborative Biovigilance System The TTSN - A Collaborative Biovigilance System 5th World Congress on Tissue Banking 12th International Conference of the APASTB Kuala Lumpur, Malaysia June 4, 2008 Scott A. Brubaker, CTBS American Association

More information

How to Find an Unrelated Donor Theory & Technology

How to Find an Unrelated Donor Theory & Technology How to Find an Unrelated Donor Theory & Technology Carlheinz R. Müller Zentrales Knochenmarkspender-Register für die Bundesrepublik Deutschland (ZKRD) Ulm, Germany How to Find an Unrelated Donor HLA-Basics

More information

Donor work up, follow up and ethical issues

Donor work up, follow up and ethical issues Donor work up, follow up and ethical issues Hans Hägglund MD. PhD. Associate Professor Hematology Center, Karolinska University Hospital, Stockholm, Sweden Outline The donor has been identified as a match

More information

EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs)

EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs) EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs) EUROPEAN REFERENCE NETWORKS FOR RARE DISEASES IN EUROPE: THE CONTEXT The need for European Reference Networks (ERNs) for rare

More information

39th SESSION OF THE SUBCOMMITTEE ON PLANNING AND PROGRAMMING OF THE EXECUTIVE COMMITTEE

39th SESSION OF THE SUBCOMMITTEE ON PLANNING AND PROGRAMMING OF THE EXECUTIVE COMMITTEE PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 39th SESSION OF THE SUBCOMMITTEE ON PLANNING AND PROGRAMMING OF THE EXECUTIVE COMMITTEE Washington, D.C., USA, 16-18 March 2005 Provisional Agenda

More information

UMBILICAL CORD BLOOD STEM CELLS EXPANDED IN THE PRESENCE OF NICOTINAMIDE (NICORD) PROVIDE LONG TERM MULITI-LINEAGE ENGRAFTMENT

UMBILICAL CORD BLOOD STEM CELLS EXPANDED IN THE PRESENCE OF NICOTINAMIDE (NICORD) PROVIDE LONG TERM MULITI-LINEAGE ENGRAFTMENT UMBILICAL CORD BLOOD STEM CELLS EXPANDED IN THE PRESENCE OF NICOTINAMIDE (NICORD) PROVIDE LONG TERM MULITI-LINEAGE ENGRAFTMENT Mitchell E. Horwitz, MD Duke University Medical Center Duke Cancer Institute

More information

Company presentation. Claudio Bordignon, Chairman and CEO. Jefferies Global Healthcare Conference New York, 7 June 2012

Company presentation. Claudio Bordignon, Chairman and CEO. Jefferies Global Healthcare Conference New York, 7 June 2012 Company presentation Claudio Bordignon, Chairman and CEO Jefferies Global Healthcare Conference New York, 7 June 2012 Forward-looking statements The presentation contains certain forward-looking statements.

More information

EU safeguards contribution to the global nuclear non-proliferation regime. Safeguards implementation in the European Union

EU safeguards contribution to the global nuclear non-proliferation regime. Safeguards implementation in the European Union 2015 Review Conference of the Parties to the Treaty on the Non-Proliferation of Nuclear Weapons 5 May 2015 NPT/CONF.2015/WP.55. Original: English New York, 27 April-22 May 2015 EU safeguards contribution

More information